Phosphorylated Tau Levels in Donated Blood for Alzheimer’s Disease
Phosphorylated Tau Levels in Donated Blood
Recruiting
Observational Study
Alzheimer&Amp;#39;s Disease
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250 (estimated)
- Sponsor
- The University of Texas Health Science Center, Houston · Other
Who this trial is looking for
This trial is looking for people who have donated blood samples. The goal is to study the levels of a specific protein related to Alzheimer’s disease in the blood to see if it can help understand risks for patients receiving blood transfusions.
Are You a Good Fit for This Trial?
You may be able to join if
- I have donated plasma.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Alzheimer's disease (AD) is characterized by the accumulation of tau pathology, and blood-based biomarkers such as phosphorylated tau-217 (pTau217) have been identified as sensitive and specific predictors of AD risk. Recent studies suggest that individuals with elevated pTau217 levels may be at increased risk for developing AD and cognitive dysfunction. This observational study will examine donat…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* The plasma sample from donators.
Exclusion Criteria:
* None.
Contacts